Actxa Showcases AI-Driven BGEM technology at TechInnovation 2025

Singapore, 23 October 2025 -  Actxa is excited to participate in TechInnovation 2025, Asia’s premier platform for innovation and business transformation, organised by IPI Singapore, where we will showcase BGEM, our AI-driven, non-invasive blood glucose prediction technology that advances the frontier of preventive health innovation.

BGEM leverages AI to predict the risk of diabetes and estimate blood glucose levels non-invasively, empowering individuals with actionable health insights that enable proactive lifestyle changes and support long-term well-being. This technology reflects Actxa’s commitment to developing science-based solutions that make preventive health accessible and effective everyday.

Learn how Actxa’s AI-driven BGEM technology is shaping the future of preventive health.

 Speaker Session 

Topic: BGEM: AI for diabetic risk screening and control 

Speaker: Dr. Du Yao, Head of Research and Development, Actxa 

Date and Time: 30 Oct, Thursday at 3.30pm 

Event Details 

Date: 29 – 31 October 2025 

Location: Sands Expo & Convention Centre, Level 3, Heliconia Ballroom 

Stand: K02

Visit our stand to learn more about BGEM and connect with our team to explore how Actxa is shaping the future of preventive health through innovation.  

Keen to speak with our team and explore collaboration opportunities? Secure your meeting slot https://forms.office.com/r/qhTpjtSQed